Clinical Trial Update: Intravenous Beta-blockade for Improvement of Autonomic Activity

View source ↗

Summary

A completed clinical trial evaluated intravenous beta-blockade for improving autonomic activity in patients with hypertension and tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Tachycardia

Drugs mentioned

• Intravenous beta-blocker (beta-blocker)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Hypertension, Tachycardia | Status: COMPLETED